Bio Path Holdings Inc (NASDAQ:BPTH)
| 1.57 Delayed Data As of Jun 02 |  -0.0985 / -5.83%Today’s Change | 1.18 Today|||52-Week Range 4.48 | +3.97% Year-to-Date |
Latest BPTH News | Press Releases
No recent news for Bio Path Holdings Inc.
Today’s Trading
| Previous close | 1.69 |
| Today’s open | 1.71 |
| Day’s range | 1.45 - 1.73 |
| Volume | 90,461 |
| Average volume (3 months) | 32,861 |
| Market cap | $12.8M |
Data as of 3:57pm ET, 06/02/2023
Growth & Valuation
| Earnings growth (last year) | -22.78% |
| Earnings growth (this year) | 0.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.81 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OTLCOncotelic Therapeuti... | +0.00 | +2.32% |
| APVOAptevo Therapeutics ... | +0.03 | +1.91% |
| IMNNImunon Inc | +0.08 | +6.84% |
| CANFCan Fite Biopharma L... | -0.00 | -0.18% |
Data as of 3:59pm ET, 06/02/2023
Financials
| Next reporting date | August 17, 2023 |
| EPS forecast (this quarter) | -$0.44 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$13.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Bellaire, Texas |
Forecasts
